Article Details
Retrieved on: 2024-11-28 14:12:27
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses the significant issue of polypharmacy, especially in elderly populations with Alzheimer's, emphasizing potential adverse effects like cognitive impairment. It explores strategies such as deprescribing and tools like the Beers Criteria to mitigate risks. The tags highlight the relevance of polypharmacy in geriatrics and clinical pharmacology contexts.
Article found on: www.pharmacytimes.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here